FTC asks judge to hold Martin Shkreli in contempt for breaking pharma ban
Shkreli received lifetime ban from industry over monopoly pricing on life-saving Daraprim drug
Shkreli received lifetime ban from industry over monopoly pricing on life-saving Daraprim drug